Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
17.10
+0.51 (3.07%)
Bozor ochiq: Aug 12, 2026, 12:29 PM EDT
16.67
+0.08 (0.49%)
Oldingi bozordan keyin: Aug 11, 2026, 7:54 PM EDT
MoonLake Immunotherapeutics, klinik bosqichdagi biotexnologiya kompaniyasi, yalligʻlanishli teri va boʻgʻim kasalliklari uchun terapiyalarni ishlab chiqishga qaratilgan. U dermatologiya va revmatologiyada yalligʻlanish kasalliklarini, shuningdek, hidradenitis suppurativa, psoriatik artrit, oʻqli spondiloartrit, palmoplantar pustuloz va psoriazni davolash uchun IL-17A va IL-17F ni ingibitsiya qiluvchi yangi uch tomonlama Nanobody Sonelokimabni ishlab chiqadi. Kompaniya 2021-yilda tashkil etilgan va uning shtab-kvartirasi Shveytsariyaning Zug shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jorge Santos da Silva Ph.D. | Co-Founder, Interim Chair of the Board & CEO |
| Dr. Kristian Reich M.D., Ph.D. | Co-Founder & Chief Scientific Officer |
| Joana Cortez | Associate Vice-President of Legal & Compliance |
| Luciana Marques | Associate Vice-President of HR, People and Culture |
| Mr. Matthias Bodenstedt | Chief Financial Officer |
| Mr. Nicolas Mosimann Ph.D. | General Counsel |
| Mr. Oliver Daltrop Ph.D. | Chief Technical Officer |
| Ms. Carla Bretes | Director of Investor Relations & External Communications |
| Ms. Nuala Brennan | Chief Clinical Development Officer |
| Tino Anthamatten | Vice President of Marketing, Market Access & Pricing |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-10 | 8-K | ea0301191-8k_moonlake.htm |
| 2026-07-15 | 8-K | ea0298054-8k_moonlake.htm |
| 2026-06-25 | 8-K | ea0295766-8k_moonlake.htm |
| 2026-06-22 | 8-K | ea0295399-8k_moonlake.htm |
| 2026-06-09 | 8-K | ea0294064-8k_moonlake.htm |
| 2026-06-01 | 8-K | ea0292693-8k_moonlake.htm |
| 2026-05-11 | 8-K | mnlk-20260510.htm |
| 2026-05-11 | 10-Q | mnlk-20260331.htm |
| 2026-04-21 | DEFA14A | ny20067252x2_defa14a.htm |
| 2026-04-21 | DEF 14A | ny20067252x1_def14a.htm |